Tissue inhibitor of metalloproteinases-I (TIMP-I) is known to have at least 2 distinct types of activity, i.e., as a regulator of collagenolytic activity, and erythroid potentiating activity (EPA). In this study, we examined the expression of TIMP-I in human mammary carcinomas, non-malignant breast
Protein and mRNA expression of tissue factor pathway inhibitor-1 (TFPI-1) in breast, pancreatic and colorectal cancer cells
β Scribed by M. A. Kurer
- Publisher
- Springer
- Year
- 2006
- Tongue
- English
- Weight
- 164 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0301-4851
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract Deep vein thrombosis associated with advanced cancer is known as Trousseau's syndrome. We hypothesized that thrombin, an activator of proteaseβactivated receptor (PAR)β1 and PARβ4 contributes to tumor metastasis. In this study, we demonstrated that thrombin and the PARβ1 activating pept
Signal transduction initiated by TGFb1 and OP-1 was studied in MG63 human osteosarcoma cells and in normal human bone cells (HBCs) in the presence of inhibitors of signal transduction events, using insulinlike growth factor binding protein-3 (IGFBP-3) production as an end point. Treatment of serum-f